The global blood culture test market is expected to reach $3.473 billion by 2019 from $2.5 billion in 2014, growing at a CAGR of 6.8%.
(PRWEB) June 26, 2015
The blood culture test market is categorized on the basis of methods, products, applications, end users, and regions. Factors such as increasing demand for rapid diagnostic techniques, high prevalence of infectious diseases, increase in healthcare expenditure and rising aging population are driving the growth of this market. Moreover, increasing bloodstream infections is another major factor propelling the growth of this market. According to the U.S. CDC (Centres for Disease Control and Prevention), catheter-related bloodstream infection (CRBSI) is the most common cause of healthcare-associated blood stream infection. Around 12% to 25% of patients who acquire BSI die every year, while some of them have to prolong their hospital stay leading to increase in the overall treatment cost. A treatment of CRBSI can cost up to $56,000, once the cost of pharmacy increases, the cost of catheter and additional diagnostic tests also increases which leads to the increase in the overall healthcare cost. Browse 178 market data tables & 31 figures spread through 250 pages and in-depth TOC on “Blood Culture Test Market" at http://www.reportsnreports.com/reports/377270-blood-culture-test-market-by-method-manual-automated-product-consumables-instrument-application-aerobic-anaerobic-yeast-fungi-end-user-hospital-reference-laboratory-clinical-laboratory-academic-research-institute-forecast-to-2019.html.
The relatively untapped Asian region provides an array of growth opportunities for the blood culture test market. A large population base, rapid urbanization, increase in blood stream infection (BSI), rising prevalence of infectious diseases, rising aging population, increasing product availability, and technological advancements are some of the factors responsible for the growth of this market.
The blood culture test market is dominated by a few major players, such as Abbott Laboratories, Alere, Inc, Bruker Corporation, Biomérieux SA, Becton, Dickinson and Company, Cepheid, Inc, F. Hoffmann-La Roche Ltd, Nanosphere, Inc, Siemens AG and Thermo Fisher Scientific, Inc. Order a copy of this report at http://www.reportsnreports.com/purchase.aspx?name=377270.
To leverage these market opportunities and to reduce the manufacturing and distribution costs, various market players are building manufacturing facilities and strengthening their sales force in these developing economies.However, high cost of automated blood culture systems and lack of adequate reimbursement are hindering the growth of this market.
Apart from the comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on the key players in the blood culture test market and their product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make informed decisions regarding product offerings, geographical focus, and change in strategic approach; R&D investments for innovations in products and technologies; and levels of output in order to remain successful. Inquire more here http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=377270.
Reasons to Buy the Report:
Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
- Market Penetration: Comprehensive information on the product portfolios of top players in the blood culture test market. The report analyzes the blood culture test market by method, product, application, end user, and region
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the blood culture test market
- Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the blood culture test market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for blood culture test products across geographies
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the blood culture test market
This is a premium research report priced at US$ 4650 for single user PDF license. Inquire for discount on this research at http://www.reportsnreports.com/contacts/discount.aspx?name=377270.
Related Market Reports:
"Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020” Companies profiled in this research report are Becton, Dickinson and Company, GE Healthcare, Abbott, Roche, Thermo Fisher Scientific, Inc, Agilent Technologies, Inc, Illumina, Inc, Siemens Healthcare and C.R. Bard, Inc discussed in this research available at http://www.reportsnreports.com/reports/402128-cancer-diagnostics-market-by-technology-elisa-elfa-pcr-ngs-immunohistochemistry-microarray-imaging-mri-ct-pet-ultrasound-mammography-biopsy-application-breast-cancer-lung-cancer-colorectal-cancer-melanoma-forecast-to-2020.html.
Explore more In Healthcare Market Research Reports at http://www.reportsnreports.com/market-research/healthcare/.
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.